Profile
Anju Chatterji currently works at HilleVax, Inc., as Chief Technology Officer from 2023.
Dr. Chatterji also formerly worked at Grifols Biologicals, Inc., as Director-Technical Development and Catalyst Biosciences, Inc., as Senior VP-Biologics Development & Manufacturing.
Dr. Chatterji received her doctorate degree from Indian Agricultural Research Institute.
Anju Chatterji active positions
| Companies | Position | Start |
|---|---|---|
| HILLEVAX, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Former positions of Anju Chatterji
| Companies | Position | End |
|---|---|---|
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Chief Tech/Sci/R&D Officer | - |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | - |
Education of Anju Chatterji
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Indian Agricultural Research Institute
Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Health Technology |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
HilleVax, Inc.
HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
- Stock Market
- Insiders
- Anju Chatterji
















